Eye Involvement in Patients with Ankylosing Spondylitis

Objective & Hypothesis:Purpose: To determine the rate of uveitic eye involvement and complications in involved eyes in patients with ankylosing spondylitisMaterial and Methods: This study involved 86 ankylosing spondilitis patients who were followed up in the physical medicine and rehabilitation clinic.

📊

Key Findings & Data:Macular thickness was measured by optical coherence tomography (OCT) to detect presence of macular edema.Results: Mean age of 86 patients (58M/28F) was 37.3±10.1 years (18-71 years).

💡

Conclusion & Impact:Patients with anterior uveitis should be investigated for ankylosing spondilitis

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Purpose: To determine the rate of uveitic eye involvement and complications in involved eyes in patients with ankylosing spondylitisMaterial and Methods: This study involved 86 ankylosing spondilitis patients who were followed up in the physical medicine and rehabilitation clinic. Medical history of the patients were evaluated. Detailed ophthalmological examination was performed in all patients. We searched for signs of old or active uveitic attacks. We measured intraocular pressure. Macular thickness was measured by optical coherence tomography (OCT) to detect presence of macular edema.Results: Mean age of 86 patients (58M/28F) was 37.3±10.1 years (18-71 years). We detected acute anterior uveitis in 6 patients and signs of old anterior uveitic attacks in 15 patients (totally 21(24.4%) patients, 15 M/6 F). We did not detect intermediate or posterior uveitis in any patient. Uveitic involvement was bilateral in 14 patients and unilateral in 7 patients. Mean IOP was 16±1.8 mmHg. Cystoid macular edema was detected in 2 patients with acute attack. 2 uveitic eyes were pseudofakic. Visual acuity was >=0.5 in all eyes except 2 eyes with uveitic cataract.Conclusion: Patients with ankylosing spondilitis should be followed up regularly for eye involvement. Patients with anterior uveitis should be investigated for ankylosing spondilitis

Özet

Amaç: Ankilozan spondilitli olgularda üveitik göz tutulumu sıklığını ve göz tutulumu olan olgularda gelişen komplikasyonları tespit etmek. Gereç ve Yöntem: Fizik tedavi ve rehabilitasyon polikliniğinde takipli ankilozan spondilit tanısı almış 86 olgu çalışma kapsamına alındı. Hastaların dosyaları tarandı. Daha önceki göz konsültasyon notları incelendi. Tüm hastalar ayrıntılı göz muayenesinden geçirildi. Geçirilmiş veya aktif üveit bulguları arandı. Göz içi basınçları ölçüldü. Tüm olgulara maküler optik koherens tomografi (OCT) çekilerek maküler ödem varlığı araştırıldı. Bulgular: 86 olgunun (58 E/28 K) yaş ortalaması 37.3±10.1 yıl (18-71 yıl ) idi. Altı olguda aktif, 15 olguda geçirilmiş olmak üzere toplam 21 (%24.4)olguda (15E/6 K) ön üveit tespit edildi. Hiçbir olguda aktif veya geçirilmiş intermediate ve arka üveit tespit edilmedi. Yirmibir olgunun 14'ünde (%66.6) üveitik tutulum çift taraflı, 7'sinde (% 33.3) tek taraflıydı. Ortalama göz içi basıncı (GİB) 16±1.8 mmHg idi. Hiçbir olguda glokom tespit edilmedi. Aktif üveitli 2 olguda OCT'de kistik maküler ödem tespit edildi. Üveiti olan 35 gözden 2'si psödofakikti. Üveitik katarakt olan 2 göz dışındaki tüm uveitli olgularda görme 0.5 ve üzerindeydi. Sonuç: Ankilozan spondilitli olgular göz tutulumu açısından düzenli bir şekilde takip edilmelidir. Akut ön üveitle başvuran olgular ankilozan spondilit açısından araştırılmalıdır

🔖

Cite This Article

BUTTANRI, İ. B., KURTULUŞ, D., SERİN, D. (2014). Eye Involvement in Patients with Ankylosing Spondylitis. Glokom Katarakt, Cilt: 9 - Sayı: 4, 267–269. https://ajindex.com/articles/205977

References (16)

JJi SX, Yin XL, Yuan RD, et al. Clinical features of ankylosing spondylitis associated with acute anterior uveitis in Chinese patients. Int J Ophthalmol 2012;5:164-6
Chan CC, Inrig T, Molloy CB, et al. Prevalence of inflammatory back pain in a cohort of patients with anterior uveitis. Am J Ophthalmol 2012;153:1025-30
Braun J, Bollow M, Remlinger G, et al. Prevelence of spondylarthropataties in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67
Rosenbaum JT. Acute anterior uveitis in spondyloarhropathies. Rheum Dis Cln North Am 1992;18:143-51
Beckingsale AB, Davies J, Gibson JM, et al. Acute anterior uveitis, ankylosing spondilitis, back pain and HLA-B27. Br. J Ophthalmol 1984;68:741-5
Brophy S, Pavy S, Lewis P, et al. Inflammatory eye, skin and bowel disease in spondyloarthritis: Genetic, phenotypic and environmental factors. J Rheumatol 2001;28:2667-73
Fernandez-Melon J, Munoz-Fernabdez S, Hidalgo V, et al. Uveitis in the initial clinical manifestation in patients with spondyloartropathies. J Rheumatol 2004;31:524-7
Rosenbaum JT. Acute anterior uveitis and spondyloartropathies. Rheum Dis Clin North Am1992;18:143-51
Kavuncu S, Özdal PÇ, Ersoy ÖD, et al. HLA B27 ile ilişkili üveiti olan hastalarda seyir ve sistemik tutulum. MN Ophthalmol 2012;19:223-8
Önal S, Kazokoğlu H, Bavbek T. HLA-B27 Ön üveiti: demografik ve klinik özellikleri. T. Oft Gaz, 2004;34:74-80
Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arhritis Rheum 1984;27:361-8
Skuta LG. Noninfectious oclar ınflammatory disease (Chapter 6). In American Academy of Ophthalmology. Skuta LG. Intraocular inflammation and uveitis. 2012:9;121
Nussenblat R, Whitcup IS, Paestine A. Anterior uveitis. in:Uveitis: Fundamentals and Clinic Practice. 2nd ed. Philadelphia: Mosby 1996;19
Michael S, Foster C. Definition, classification, etiology and epidemiology. In foster and vitale, eds. diagnosis and treatment of uveitis. Orlondo: WB Saunders Company 2002;3
Braakenburg AMD, Valk HWD, Boer JD, et al. Human leucocyte antigen-b27- associated uveitis: long-term follw-up and gender differences. Am J Ophthalmol 2008;145:472-9
Lee W, Reveille JD, Davis JC Jr, et al. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2007;66:663-8.